{"id":"W3172791693","doi":"10.1200/jco.2021.39.15_suppl.9569","title":"Analysis of patients (pts) with in-transit metastases treated with nivolumab (NIVO) or ipilimumab (IPI) in CheckMate 238.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Clinical endpoint; Oncology; Population; Adjuvant; Clinical trial; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006254838,0.0003517448,0.0009704151,0.0001907708,0.0002091131,0.0004311052,0.0002836745,0.0005497482,0.002092805],"category_scores_gemma":[0.0005931584,0.0002223708,0.001352169,0.0003428137,0.0002576058,0.0002966436,0.0002773053,0.000823733,0.0003034747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005009266,"about_ca_system_score_gemma":0.0004948424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009020073,"about_ca_topic_score_gemma":0.001238361,"domain_scores_codex":[0.9996935,0.00009267244,0.00002314927,0.00009551538,0.00003993584,0.00005525171],"domain_scores_gemma":[0.9996023,0.0001068514,0.00009256276,0.00002777873,0.0000160366,0.0001543984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5451745,0.004964994,0.3862846,0.0004987531,0.002668807,0.001036841,0.0001905751,0.002183676,0.02019044,0.0001620441,0.002079298,0.0345655],"study_design_scores_gemma":[0.04220494,0.1075217,0.8360026,0.00005533475,0.002575949,0.00113842,0.0001938832,0.003184621,0.002652217,0.0002532988,0.004167693,0.00004936687],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982572,0.0004474635,0.0001306488,0.00003640042,0.00001518539,0.00009834799,0.0006234155,0.000004838411,0.0003863764],"genre_scores_gemma":[0.9979225,0.0001397535,0.0001492895,0.0001089754,0.00003407362,0.0001331246,0.001164057,0.000002931191,0.0003453959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002092805,"threshold_uncertainty_score":0.007001162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07024500424129045,"score_gpt":0.4155460451486779,"score_spread":0.3453010409073874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}